Objectives. Patients with aortic aneurysms have significant comorbidities which influence outcome. Our practice includes comprehensive assessment to identify comorbidities, allowing subsequent medical optimisation prior to aneurysm repair. The aim of this study was to assess this process and to identify any factors predictive of outcome. Design. Prospective observational study. Materials. Medical case notes of 200 patients referred with aortic pathology. Methods. Data analysed included preoperative, perioperative and postoperative factors. Multiple logistic regression analysis was performed to identify predictors of outcome. Results. Following assessment 17 patients (8.5%) were found to be unfit for intervention and 165 patients (82.5%) proceeded to aneurysm repair. In this group assessment uncovered previously undiagnosed cardiac, respiratory and renal comorbidity in 19%, 57% and 29% of patients respectively. Multiple logistic regression analysis indicated that optimisation by a renal physician reduced post-operative renal impairment (OR 0.12, 95% CI 0.03e0.45, P ¼ 0.002) while optimisation by a cardiologist reduced respiratory complications (OR 0.7, 95% CI 0.05e0.99, P ¼ 0.049). An abnormal echocardiogram was associated with pneumonia (OR 6.9, 95% CI 1.6e29, P ¼ 0.01) and death (OR 7.9, 95% CI 1.15e54, P ¼ 0.036). Conclusion. Pre-operative assessment identifies previously undiagnosed comorbidity in a significant proportion of patients. Subsequent medical optimisation may reduce post-operative morbidity and mortality.
Introduction
The majority of patients with aortic aneurysms are elderly with multiple co-morbidities, and as a result are high-risk surgical candidates. 1 This is reflected by complication rates of approximately 30% following conventional elective abdominal aortic aneurysm (AAA) repair. 2, 3 Mortality is principally due to cardiac causes, accounting for up to one half of all deaths. 4e6 Respiratory complications comprise the second commonest cause of death, 4 and renal dysfunction has been associated with high mortality. 7 Modification of risk factors that can be identified preoperatively may improve outcome for these patients. 1 Methods available to stratify surgical risk include history and examination, combined with investigations that aim to assess physiological reserve and identify underlying pathology. 8 Although manipulation of cardiac risk factors has formed the focus of the majority of studies regarding morbidity and mortality in elective aortic aneurysm repair, the presence of pulmonary disease and renal impairment should not be overlooked. 1 It is our practice to pass all patients referred with aortic pathology through a comprehensive assessment and optimisation regime. This aids decision making for the surgeon, improves informed consent for the patient and identifies risk factors that can be modified prior to aneurysm repair. This study was designed to evaluate how effective this process is in identifying undiagnosed comorbidity, the effect on morbidity and mortality, and to identify any factors that may predict outcome.
Materials and Methods
This was a prospective observational study of 200 patients referred for elective aneurysm repair between January 2003 and June 2005. The following preoperative, perioperative and postoperative data was collected from patients notes using a standardised data collection form, and subjected to multivariate stepwise logistic regression analysis.
Preoperative data consisted of age, sex, aneurysm type, medical and drug history, smoking status, body mass index (BMI) and American Society of Anesthesiologists (ASA) grade. All patients were subject to a standard assessment and optimisation protocol which consisted of history and examination, routine blood tests, resting electrocardiogram (ECG), static echocardiogram, arterial blood gases (ABGs), pulmonary function tests (PFTs) and an axial CT scan of the aorta. ECGs were considered abnormal if they displayed ischaemic changes (Q waves or ST segment abnormalities), rhythm abnormalities or conduction defects. An abnormal echocardiogram was defined as one demonstrating left ventricular dilatation or hypertrophy, impaired systolic function, regional wall motion abnormalities or aortic stenosis. PFTs were considered abnormal if they revealed an forced expiratory volume in 1 second (FEV 1 ) of less than 80% of that predicted (British Thoracic Society COPD Guidelines 2004). ABGs were considered abnormal if they revealed hypoxia (PO 2 < 8 kPa), or hypercarbia (PCO 2 > 7 kPa). Serum creatinine was used as a surrogate marker of renal function and was defined as abnormal if it was above 110 mmol/L. Subsequent referral to a medical specialist was guided by the results of the assessment and the outcome of the referral was recorded.
Perioperative data consisted of anaesthetic type, length of operation, blood loss, and duration of ITU stay. Postoperative outcomes consisted of complications and death.
Statistical analysis
Continuous variables were not normally distributed and therefore expressed as medians with interquartile range (IQR). Discrete variables were expressed as numbers and percentages. We investigated the association between the preoperative and perioperative variables and complications and death using multivariate stepwise logistic regression, in order to identify any independent predictors of complications and death. A P-value of less than 0.05 was considered statistically significant. Statistical analysis was performed utilising SPSS 12.0 software (SPSS, Inc., Chicago, IL).
Results
Following assessment 165 of the 200 patients referred proceeded to aneurysm repair. There were 140 abdominal aortic aneurysm repairs, of which 33 were open (OAAA) and 107 were endovascular (EVAR). Seventeen thoracic aneurysms (TA) all underwent endovascular repair and 8 thoraco-abdominal aneurysms (type IV) all underwent open repair. Seventeen patents were found to be unfit for intervention (12 AAA, 3 TA, 2 type-IV). A further 18 patients didn't receive intervention for other reasons; entered surveillance programmes (7), patient refused intervention (5), death prior to repair (3), conservative arm of EVAR 2 trial (2), patient returned to referring hospital (1) . Unless otherwise stated the following data refer to those patients that underwent aneurysm repair.
Known comorbidity
It can be seen that the extent of known comorbidity prior to assessment was considerable (Table 1) . There was a history of cardiac disease in 63.6% of patients. This included 53.3% with coronary artery disease (angina 32.7%, previous myocardial infarction 39.4%, previous coronary artery bypass graft 15.8% or angioplasty 7.3%). In addition to statins, b-blockers and aspirin, 74.5% of patients took additional cardiac medications (calcium channel blockers, diuretics, , systolic dysfunction present in 26%, regional wall motion abnormalities present in 36.4% and aortic stenosis in 9.1%. Pulmonary function tests revealed COPD in half of the patients, and ABGs were abnormal in 59% (55.5% with hypoxia and 7.2% with hypercarbia). Renal impairment was detected in 41.2% of patients. In the patients that were deemed unfit for aneurysm repair the burden of disease was even higher, with a greater proportion of abnormal results in all investigations.
Effect of assessment
As a result of assessment previously undiagnosed cardiac comorbidity was revealed in 19% of patients, respiratory comorbidity in 57% and renal comorbidity in 29% (Fig. 1) . Following assessment the total percentage of patients with identified cardiac disease was 83%, respiratory disease 81%, and renal disease 45%.
Optimisation
Forty four percent of cases were referred to a cardiologist, 32% to a respiratory physician and 16% to a renal physician. The patients referred to a cardiologist included those with newly-diagnosed cardiac disease and those with symptoms suggesting unstable disease. The remaining patients with cardiac disease that were not referred had known stable disease and had previously been reviewed by a cardiologist prior to assessment. Of the cardiology referrals, 55% resulted in a change in management (75% change in medications, 23% referred for CABG or coronary stent, 2.5% referred for pacemaker). Of the respiratory referrals 63% resulted in a change of management, all consisting of medication changes. Of the renal referrals, 23% resulted in a change of management (50% drug change, 50% planned peri-operative dialysis).
Perioperative factors
Perioperative data included in the regression analysis are shown in Table 2 .
Morbidity and mortality
Cardiac complications occurred in 14.5% (9.7% acute coronary syndrome and 4.8% left ventricular failure). Respiratory complications occurred in 12.1% (8.5% pneumonia and 3.6% respiratory failure) and renal failure occurred in 9% with no long-term dialysis requirement or death. Other complications included bowel ischaemia (1.2%) and cerebrovascular accident (1.2%). In total there were 6 deaths due to myocardial infarction, bronchopneumonia, cerebrovascular accident, ischaemic heart disease, small bowel infarction and septicaemia. The mortality was distributed as follows: 1/33 OAAA (3.0%), 4/107 EVAR (3.7%) and 1/8 type-IV (12.5%). Observed mortality compared favourably to P-POSSUM predicted mortality for both open and endovascular infra-renal aneurysm repair (3.0% vs 8.3% and 3.7% vs 8.1% respectively). As P-POSSUM scoring has not been validated in suprarenal aneurysm repair comparisons were not made in these groups.
Multiple logistic regression analysis
Multiple regression analysis indicated that an abnormal echocardiogram was associated with postoperative pneumonia (OR 6.9, 95% CI 1.6e29, P ¼ 0.01) and death (OR 7.9, 95% CI 1.15e54, P ¼ 0.036). Pre-operative intervention by a renal physician was associated with a reduction in post-operative renal impairment (OR 0.12, 95% CI 0.03e0.45, P ¼ 0.002) and pre-operative intervention by a cardiologist was associated with a reduction in respiratory complications (OR 0.7, 95% CI 0.05e0.99, P ¼ 0.049).
Discussion
Mortality rates associated with aneurysm repair do not take into consideration the effect of pre-existing risk factors. 6 The identification of modifiable risk factors provides the opportunity for medical optimisation, which may improve functional deficits associated with perioperative death. 8 Methods available to stratify surgical risk include a history and examination, combined with investigations that aim to assess physiological reserve and identify underlying pathology. 8 Angina, heart failure and a previous history of myocardial infarction have all been associated with increased perioperative death.
6e8 Similarly, ECG evidence of ischaemic heart disease or ventricular ectopics have also been associated with increased risk. 6 Ejection fraction measurements using echocardiograms have been used to define high-risk patients. 9 Low FEV 1 has been strongly associated with postoperative mortality, 10 and exercise capacity has shown a clear effect on mortality. 6 Renal dysfunction and elevated serum creatinine has been associated with postoperative mortality following elective AAA surgery. 7, 8, 10 Our system is therefore based around these discriminatory investigations.
With the growing evolution of endovascular techniques, minimally invasive aneurysm repair has become established in many centres. Although potentially associated with reduced morbidity and mortality, we would now consider endovascular repair in patients previously deemed unfit for open repair. This is a tertiary referral centre which attracts patients with complex aneurysm disease and those deemed unfit for repair. The 30 day mortality rate following EVAR of AAA in this study (3.7%) allows us to continue to consider 'unfit' patients for endovascular repair, despite the results of the EVAR 2 trial (9% 30 day mortality). However, we continually audit this practice. This study highlights the burden of disease in this cohort of patients, and the necessity for medical optimisation to improve morbidity and mortality.
Vascular surgeons that carry out high volume surgery are more aggressive in their assessment of cardiac risk prior to reconstruction, 11 but it would seem that assessment is generally not comprehensive. Although 93% of surgeons routinely carry out blood tests, 1 routine ECG occurred in only 68%, 1 with routine echocardiograms being performed in 25e47%. 1, 6, 11 One possible concern is the costeffectiveness of such an intensive preoperative optimisation package. However this must be balanced by the potential reduction in ITU stay, morbidity and mortality. It has been suggested that stress echocardiogram should replace static echocardiogram as a superior investigation for revealing underlying cardiac dysfunction prior to surgery. This is a matter for discussion, and our protocol is flexible, reserving certain investigations for select groups, such as dynamic cardiac studies in those patients undergoing open thoracic surgery, or following recommendation from a cardiologist. Another possible criticism of this optimisation regime is that it may delay aneurysm repair. In our unit a system has been developed with a vascular nurse practitioner in which all investigations are carried out in one day. If intervention is required by a specialist patients are kept in overnight. With this system we have not experienced any delay in aneurysm repair.
This study has demonstrated that patients deemed unfit for intervention have much worse cardiorespiratory function. But how is 'fitness for intervention' assessed? We use a multi-disciplinary team approach involving surgeons, anaesthetists and intensivists. We base our decision on the multiple data uncovered by the assessment and optimisation process. Therefore, due to the individually tailored approach it is very difficult to construct a protocol to decide who is unfit for intervention. This may explain why 85% of vascular surgeons were found not to use any form of 
Limitations of study
One potential criticism is that this series contains mixed pathologies of the aorta and different intervention modalities, which may lead to a wide variation of complication rates. We included all patients referred for aortic surgery because every patient is initially treated identically by being subjected to the same assessment and optimisation regime. We found that patients with mixed aortic disease had similar preoperative comorbidities irrespective of specific pathology, and the inclusion of all patients highlights the impact of optimisation within our normal working practice. Another possible criticism is the inclusion of patients that were part of the EVAR trials, as treatment decisions may be based on randomisation and not clinical background. Twenty patients were recruited into EVAR 1, and the decision to operate was based on the assessment and optimisation regime, in the same way as non-trial patients, with only the treatment modality being subject to randomisation. Seven patients underwent aneurysm repair as part of the EVAR 2 trial. Due to advances in EVAR techniques these patients are representational of the other patients with significant comorbidity included in the study that we now consider suitable for EVAR. This is corroborated by the fact that 88% of all our patients were ASA 3e4.
Conclusion
Our practice allows us to identify previously undiagnosed, significant co-morbidity in a large proportion of patients. It identifies unfit candidates aiding patient selection and allows for targeted medical optimisation of modifiable risk factors in surgical candidates. Optimisation may be associated with a reduction in post-operative complications resulting in satisfactory mortality rates.
